Rebalix
UBS · sheet of 5 September 2026
UBS · sheet of 5 September 2026ETF sheet · official issuer and register data
UBS Core MSCI World UCITS ETF USD dis
IE00B7KQ7B66 · IE00B7KQ7B66 · USD · domicile Ireland
Equity · GlobalSFDR art. 6
Index tracked: MSCI World Total Return Net
- TER
- 0.06%+ trans. 0.00%
- Fund size
- 1.9 bn EUR
- Tracking difference
- +0.13%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical (full replication)
- Income
- Distributingsemi-annual
Launch 11 Apr 2012 · costs from the KID as of 2 Sept 2026 · 0 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and seeks to track performance of the MSCI World Index (Net Return) (the 'Index'). The Index is designed to measure the performance of mid and large capitalization companies which are listed on worldwide markets. The Fund will seek to hold all of the shares of the Index, in the same proportions as the Index, so that essentially the portfolio of the Fund will be a near mirror image of the Index. In seeking to implement its investment objective of tracking the performance of the Index, the Fund may also in exceptional…
Performance since series start (in euro) — base 100
11 Apr 2012 → 3 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +22.7% |
| 3 years | +63.4% |
| 5 years | +74.0% |
| 10 years | +226.6% |
| Since series start | +468.7% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 11.67% | 12.78% | 14.74% |
| Max drawdown | −9.07% | −16.54% | −27.28% |
| Sharpe | 1.46 | 1.18 | 0.53 |
| Sortino | 2.17 | 1.71 | 0.76 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00B7KQ7B66 · IE00B7KQ7B661
RebalixIE00B7KQ7B66 · IE00B7KQ7B66 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +21.31% | +21.09% | +0.21% |
| 2024 | +18.86% | +18.67% | +0.19% |
| 2023 | +23.79% | +23.79% | +0.00% |
| 2022 | −18.26% | −18.14% | −0.12% |
| 2021 | +21.63% | +21.82% | −0.19% |
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 1.7129 USD (1.37% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 1.7129 | — |
| 2025 | 2 | 1.6395 | +1.76% |
| 2024 | 2 | 1.2994 | +1.63% |
| 2023 | 2 | 1.1384 | +1.74% |
| 2022 | 2 | 1.0512 | +1.29% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 31 Jul 2026 · 0 securities · top-10 weight = 26.4%
| Top holdings | Weight |
|---|---|
| 5.2% | |
| 5.1% | |
| 3.7% | |
| 2.9% | |
| 2.3% | |
| 2.0% | |
| 1.8% | |
| 1.4% | |
| 1.1% | |
| 1.0% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
UBU7 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Amsterdam, Tradegate Exchange, Xetra (Deutsche Börse)
+ 19 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · www.ubs.com/2/e/files/ubs_irl_etf_plc_peit.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00B7KQ7B66
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00B7KQ7B66
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE00B7KQ7B66 · IE00B7KQ7B662